Alpha Tau Medical Ltd./$DRTS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Ticker
$DRTS
Sector
Primary listing
Employees
121
Headquarters
Jerusalem, Israel
Website
DRTS Metrics
BasicAdvanced
$848m
-
-$0.53
1.05
-
Price and volume
Market cap
$848m
Beta
1.05
52-week high
$10.80
52-week low
$2.78
Average daily volume
588k
Financial strength
Current ratio
7.452
Quick ratio
6.992
Long term debt to equity
16.336
Total debt to equity
17.803
Interest coverage (TTM)
-121.87%
Profitability
EBITDA (TTM)
-41.056
Effective tax rate (TTM)
-0.28%
Management effectiveness
Return on assets (TTM)
-27.55%
Return on equity (TTM)
-61.00%
Valuation
Price to book
11
Price to tangible book (TTM)
11
Price to free cash flow (TTM)
-23.715
Free cash flow yield (TTM)
-4.22%
Free cash flow per share (TTM)
-0.406
Growth
Earnings per share change (TTM)
16.51%
3-year earnings per share growth (CAGR)
-0.15%
DRTS News
AllArticlesVideos
Alpha Tau Medical Stock Surges As Interim Brain Tumor Trial Data Sparks Rally
Benzinga·3 days ago
Alpha Tau Medical Shares Early REGAIN Data: 2 Complete Responses in Glioblastoma Study
MarketBeat·3 days ago
HekaBio and Alpha Tau Medical Obtain Approval in Japan for Solid Tumor Treatment Alpha DaRT
Business Wire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Alpha Tau Medical Ltd. stock?
Alpha Tau Medical Ltd. (DRTS) has a market cap of $848M as of May 14, 2026.
What is the P/E ratio for Alpha Tau Medical Ltd. stock?
The price to earnings (P/E) ratio for Alpha Tau Medical Ltd. (DRTS) stock is 0 as of May 14, 2026.
Does Alpha Tau Medical Ltd. stock pay dividends?
No, Alpha Tau Medical Ltd. (DRTS) stock does not pay dividends to its shareholders as of May 14, 2026.
When is the next Alpha Tau Medical Ltd. dividend payment date?
Alpha Tau Medical Ltd. (DRTS) stock does not pay dividends to its shareholders.
What is the beta indicator for Alpha Tau Medical Ltd.?
Alpha Tau Medical Ltd. (DRTS) has a beta rating of 1.05. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.